🔗 Permalink

Inventor profile of:

Robert A. Lazarus

City:

Millbrae, California

Country:

United States

Published Applications:

Last publication date:

2023-12-28

Top Assignees for applications by Robert A. Lazarus

The entities that hold a legal rights for patent applications filed by inventor Lazarus Robert A.:

Genentech, Inc. 21 South San Francisco, CA United States
RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY 1 New Brunswick, NJ United States
Genetech, Inc. 1 South San Francisco, CA United States
CURIS, INC. 1 Lexington, MA United States

Recent patent applications by Lazarus Robert A.

Robert A. Lazarus from Millbrae, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2023-12-28

US20230416825A1

Chemistry; metallurgy

USE OF KLK5 ANTAGONISTS FOR THE TREATMENT OF A DISEASE

#2 | 2019-02-21

US20190054138A1

Human necessities

METHODS AND COMPOSITIONS FOR MODULATING HGF/MET

#3 | 2017-06-22

US20170174733A1

Chemistry; metallurgy

Chagasin-based scaffold compositions, methods, and uses

#4 | 2017-04-20

US20170106042A1

Human necessities

METHODS AND COMPOSITIONS FOR MODULATING HGF/MET

#5 | 2017-03-02

US20170058049A1

Chemistry; metallurgy

Nucleic acid molecules encoding for BACE1 antibodies

#6 | 2016-02-04

US20160032013A1

Chemistry; metallurgy

Method of reducing blood glucose by administering RON agonists

#7 | 2015-05-07

US20150126448A1

Physics

METHODS AND COMPOSITIONS FOR MODULATING HGF/MET

#8 | 2014-09-25

US20140286963A1

Chemistry; metallurgy

Methods and compositions for neural disease immunotherapy

#9 | 2013-06-06

US20130143813A1

Human necessities

METHODS AND COMPOSITIONS FOR MODULATING HGF/MET

#10 | 2013-04-18

US20130096072A1

Chemistry; metallurgy

Zymogen activators

#11 | 2012-06-14

US20120148599A1

Chemistry; metallurgy

BACE1 antibodies

#12 | 2011-07-21

US20110177058A1

Human necessities

METHODS AND COMPOSITIONS FOR MODULATING HGF/MET

#13 | 2011-06-02

US20110129457A1

Chemistry; metallurgy

Variant Hhip1 protein and methods and uses thereof

#14 | 2010-08-19

US20100210826A1

Chemistry; metallurgy

HGF β chain variants

#15 | 2010-02-18

US20100040634A1

Human necessities

METHODS AND COMPOSITIONS FOR MODULATING HGF/MET

#16 | 2008-11-27

US20080293121A1

Chemistry; metallurgy

HUMAN DNASE I HYPERACTIVE VARIANTS

#17 | 2008-08-14

US20080195366A1

Chemistry; metallurgy

CRYSTAL STRUCTURE OF THE HEPATOCYTE GROWTH FACTOR AND METHODS OF USE

#18 | 2007-08-14

US9332886

Enzymes for the production of 2-keto-L-gulonic acid

#19 | 2007-06-07

US20070129301A1

Human necessities

METHODS AND COMPOSITIONS FOR MODULATING HGF/MET

#20 | 2007-01-16

US10356257

FVIIa antagonists

#21 | 2006-12-28

US20060293235A1

Chemistry; metallurgy

HGF beta chain variants

#22 | 2006-08-01

US10202915

FVIIa antagonists

#23 | 2006-02-16

US20060035278A9

Human necessities

Methods and compositions for modulating HGF/Met

#24 | 2006-01-26

US20060019893A1

Chemistry; metallurgy

Factor VIIa variants

#25 | 2006-01-05

US20060003931A1

Chemistry; metallurgy

Crystal structure of the hepatocyte growth factor and methods of use

#26 | 2005-08-04

US20050170365A1

Chemistry; metallurgy

Human DNase I hyperactive variants

#27 | 2005-02-17

US20050037431A1

Human necessities

Methods and compositions for modulating HGF/Met

InventorID:

198746 ⎘